Vaccinogen's Series B - III Round

Vaccinogen raised a round of funding on March 22, 2013.

Vaccinogen is a cancer vaccine company developing OncoVAX as a treatment to prevent the recurrence of colon cancer and potentially other solid tumors. Vaccinogen has developed and patented a process t…

Articles about Vaccinogen's Series B - III Round: